UBS reiterates Buy rating on Hindustan Unilever stock with favorable outlook

UBS has reiterated its Buy rating on Hindustan Unilever (HUL) with a price target of INR2,800.00, citing an increasingly favorable risk-reward profile. The investment bank anticipates a sequential improvement in Q1FY26 volume growth, leading to a significant revival in H2FY26, which is expected to drive double-digit earnings growth through FY27. Despite projected lower margins in H1FY26, UBS forecasts a reversal in H2FY26 due to operating leverage, estimating an 18% upside in its base case and up to 38% in its upside scenario, signaling a strong potential turnaround for the consumer goods company.

Analysis

UBS has reaffirmed its bullish stance on Hindustan Unilever Ltd (HUVR:IN) by reiterating a Buy rating and a price target of INR 2,800.00, citing an increasingly favorable risk-reward profile. The bank's thesis hinges on a projected inflection point in the company's performance, anticipating a sequential improvement in volume growth in Q1FY26 that will set the stage for a significant revival in the second half of the fiscal year. While management has guided for lower margins in H1FY26, UBS forecasts a reversal in H2FY26 as operating leverage improves, which is expected to drive double-digit earnings growth that continues into FY27. This outlook is supported by favorable base effects and the company's own portfolio-level growth initiatives. UBS's scenario analysis quantifies the potential, projecting an 18% upside in its base case and a substantial 38% gain in its upside case, suggesting that near-term margin pressure is a temporary headwind before a fundamental recovery takes hold.

Key Decisions for Investors

• Investors with a medium-term horizon could consider the guided margin weakness in H1FY26 a strategic opportunity to accumulate positions ahead of the anticipated recovery in the second half of the year.
• Monitor the company's Q1FY26 results closely for evidence of sequential volume growth, as this is the key leading indicator for the double-digit earnings acceleration thesis.
• Portfolio managers should weigh the potential 18% base-case upside against the risk that the volume revival or operating leverage improvements in H2FY26 do not materialize as strongly as forecasted.
• For existing holders, the analysis supports maintaining the position through the near-term volatility, with the investment case predicated on a successful second-half execution.